更正：CDK4/6 抑制剂通过 USP51-ZEB1 依赖性去泛素化机制阻止癌症转移

IF 40.8 1区医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY

Signal Transduction and Targeted Therapy Pub Date : 2024-10-04 DOI:10.1038/s41392-024-01972-4

Zhen Zhang, Jianjun Li, Yang Ou, Guang Yang, Kaiyuan Deng, Qiong Wang, Zhaoyang Wang, Wenhao Wang, Quansheng Zhang, Hang Wang, Wei Sun, Peiqing Sun, Shuang Yang

引用次数: 0

摘要

Correction to：信号转导与靶向治疗》（2020年）5:25；https://doi.org/10.1038/s41392-020-0118-x，2020年3月11日在线发表

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Correction: CDK4/6 inhibition blocks cancer metastasis through a USP51-ZEB1-dependent deubiquitination mechanism

Correction to: Signal Transduction and Targeted Therapy (2020) 5:25; https://doi.org/10.1038/s41392-020-0118-x, published online 11 March 2020

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Signal Transduction and Targeted Therapy Biochemistry, Genetics and Molecular Biology-Genetics

CiteScore

44.50

自引率

1.50%

发文量

384

审稿时长

5 weeks

期刊介绍： Signal Transduction and Targeted Therapy is an open access journal that focuses on timely publication of cutting-edge discoveries and advancements in basic science and clinical research related to signal transduction and targeted therapy. Scope: The journal covers research on major human diseases, including, but not limited to: Cancer,Cardiovascular diseases,Autoimmune diseases,Nervous system diseases.